R&D News | pharmaphorum

News

FDA clears cardiovascular claim for J&J’s Invokana

Johnson & Johnson finally has some good news to report for its diabetes blockbuster Invokana, after the FDA approved a new cardiovascular outcome claim on its label.

News

Dicerna agrees another gene-silencing deal, this time with L...

Eli Lilly has agreed a broad collaboration with Dicerna, sealing the deal with a $100 million equity stake in the RNA interference specialist.

News

Pfizer and Novartis collaborate to find liver disease therap...

Pfizer has joined forces with Novartis to bring together the therapies they have been working on independently, to treat non-alcoholic steatohepatitis (NASH).

News

Zytiga generics looming as US court nixes J&J patent

Johnson & Johnson has lost another round in its patent defence for prostate cancer blockbuster Zytiga, raising the possibility that generics could launch in the coming days.

News

Takeda proposes selling Shire’s IBD treatment after merger

Takeda has proposed selling off a Shire treatment for inflammatory bowel disease when the companies merge next year, to avoid an overlap with its own drug.

News

Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms.

Magic mushroom drug could be depression breakthrough, says F...

The liberty cap mushroom, notoriously used illegally as a psychoactive drug, could be the inspiration for a new therapy for depression according to the US drug regulator.

FDA clears cardiovascular claim for J&J’s Invokana

Dicerna agrees another gene-silencing deal, this time with L...

Pfizer and Novartis collaborate to find liver disease therap...

Zytiga generics looming as US court nixes J&J patent

Takeda proposes selling Shire’s IBD treatment after merger

Magic mushroom drug could be depression breakthrough, says F...

Bayer plans filings for cardiac amyloidosis imaging agent

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks